| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/17/2006 | US7122520 Nucleotide sequences coding polypeptide for use in the eating disorders |
| 10/17/2006 | US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics |
| 10/17/2006 | US7122382 Synthesizing a protein having a label for detection and another protein having a modification for separation in a single system by the cell-free protein synthesis; separating a pair of proteins formed by the interaction between these proteins |
| 10/17/2006 | US7122374 For immunotherapy for the treatment of diseases, e.g., neurodegenerative diseases |
| 10/17/2006 | US7122369 Corynebacterium, Brevibacterium; culture product |
| 10/17/2006 | US7122366 Comprises genetically engineered aspartic protease for use in food processing; improving cocoa flavoring; odors |
| 10/17/2006 | US7122354 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy |
| 10/17/2006 | US7122351 Dimerized PDGF-D and materials and methods for producing it |
| 10/17/2006 | US7122350 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex |
| 10/17/2006 | US7122349 Human zven proteins |
| 10/17/2006 | US7122347 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine |
| 10/17/2006 | US7122346 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies |
| 10/17/2006 | US7122345 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 10/17/2006 | US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled |
| 10/17/2006 | US7122339 Method for generating diversity |
| 10/17/2006 | US7122327 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states |
| 10/17/2006 | US7122320 Method for detecting acid-resistant microorganisms in the stool |
| 10/17/2006 | US7122302 Method for determining early HCV seroconversion |
| 10/17/2006 | US7122197 Compounds from Moraxella catarrhalis |
| 10/17/2006 | US7122196 Compounds and methods for diagnosis of tuberculosis |
| 10/17/2006 | US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody |
| 10/17/2006 | US7122184 Monoclonal antibody for use in prevention of fungal infections |
| 10/17/2006 | CA2293808C Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 10/17/2006 | CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 10/17/2006 | CA2177179C Antagonists to chaperonin 10 |
| 10/17/2006 | CA2150497C Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 10/12/2006 | WO2006106970A1 Process for production of protein having triple-helical structure |
| 10/12/2006 | WO2006106959A1 Anti-cd-20 monoclonal antibody |
| 10/12/2006 | WO2006106957A1 Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same |
| 10/12/2006 | WO2006106950A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
| 10/12/2006 | WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same |
| 10/12/2006 | WO2006106905A1 Process for production of polypeptide by regulation of assembly |
| 10/12/2006 | WO2006081320A3 Pharmaceutical formulation |
| 10/12/2006 | WO2006020258A3 Novel tetravalent bispecific antibody |
| 10/12/2006 | WO2005089262A3 Novel peanut skin extract as a vaccine adjuvant |
| 10/12/2006 | WO2005081926B1 Thrombomodulin derivatives and conjugates |
| 10/12/2006 | WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 10/12/2006 | WO2004112703A3 Interleukin-21 analogs |
| 10/12/2006 | WO2003073821A3 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER |
| 10/12/2006 | US20060230470 Promoter expressing foreign gene in root and shoot apex |
| 10/12/2006 | US20060230467 Plant deoxyribonucleoside kinase enzymes and their use |
| 10/12/2006 | US20060230465 K203 gene and protein |
| 10/12/2006 | US20060229438 Monoclonal antibody derived peptide inhibitors for mycobacterial dna gyrase |
| 10/12/2006 | US20060229435 Lymphocyte homing receptors |
| 10/12/2006 | US20060229434 Low-molecular weight peptides inhibiting ion channel activity |
| 10/12/2006 | US20060229272 or biological fragments in a colon test sample and comparing to that from a normal colon sample, wherein an increased expression level is indicative of gastrointestinal disorders or a predisposition to gastrointestinal disorders |
| 10/12/2006 | US20060229250 Ghrelin associated peptide and its uses |
| 10/12/2006 | US20060229223 Having specific base substitutions and improved thermostability; controlling pitch troubles in pulping or papermaking; detergents; removing hydrophobic esters from fabrics; catalyst for hydrolysis or synthesis of esters |
| 10/12/2006 | US20060228791 Subtilases and subtilase variants having altered immunogenicity |
| 10/12/2006 | US20060228790 L-glutamate oxidase |
| 10/12/2006 | US20060228783 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 10/12/2006 | US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders |
| 10/12/2006 | US20060228781 Synthetic gene coding for human granulocyte-colony stimulating factor for the expression in e.coli |
| 10/12/2006 | US20060228780 Chromatographic method and system for purifying a botulinum toxin |
| 10/12/2006 | US20060228779 Method for producing factor G derived from horseshoe crab |
| 10/12/2006 | US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 10/12/2006 | US20060228777 Animal product free media and processes for obtaining a botulinum toxin |
| 10/12/2006 | US20060228776 PINK-1 promoter |
| 10/12/2006 | US20060228775 Differential expression of nucleic acid molecules |
| 10/12/2006 | US20060228774 Oxygen-resistant hydrogenases and methods for designing and making same |
| 10/12/2006 | US20060228773 Method for preparing recombinant heterocarpine |
| 10/12/2006 | US20060228763 Periostin-based diagnostic assays |
| 10/12/2006 | US20060228761 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 10/12/2006 | US20060228757 Identification and characterization of the receptor for leptin, including a naturally occurring soluble form; used in gene therapy or in soluble form as an agonist or antagonist of leptin activity, or diagnostically; obesity |
| 10/12/2006 | US20060228753 Methods of detecting a phenotype of a polymorphic protein |
| 10/12/2006 | US20060228731 Compositions and methods of using a synthetic DNase I |
| 10/12/2006 | US20060228724 Assays for screening presence of variant NTE nucleotide sequences in sample; therapeutic agents, ligands, and modulators |
| 10/12/2006 | US20060228715 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 10/12/2006 | US20060228712 Incubating the polynucleotide array with at least one of a labeled polynucleotide derived from a coryneform bacterium, a labeled polynucleotide derived from a mutant of the coryneform bacterium or a labeled polynucleotide,detecting any hybridization, analyzing |
| 10/12/2006 | US20060228710 Novel therapeutic targets in cancer |
| 10/12/2006 | US20060228709 Novel fibulin-like polypeptides |
| 10/12/2006 | US20060228706 Methods of diagnosing and treating diabetes and insulin resistance |
| 10/12/2006 | US20060228705 Cancer-linked gene as target for chemotherapy |
| 10/12/2006 | US20060228446 improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes; reduction of dough stickiness when they are added to a dough |
| 10/12/2006 | US20060228445 biosynthesis producing vinegar; using the genes of acetobacter to encode a protein involved in shortening the growth promotion and resistance to acetic acid in the presence of a high acetic acid concentration; genetic engineering |
| 10/12/2006 | US20060228378 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 10/12/2006 | US20060228377 Gram-positive bacteria deprived of HtrA protease activity and their uses |
| 10/12/2006 | US20060228372 Methods for modulating angiogenesis |
| 10/12/2006 | US20060228370 7a5/Prognostin and use thereof for the diagnostic and therapy of tumors |
| 10/12/2006 | US20060228365 Protein and gene involved in myocyte differentiation |
| 10/12/2006 | US20060228363 Monoclonal antibody therapy for pancreas cancer |
| 10/12/2006 | US20060228362 Novel protease gene |
| 10/12/2006 | US20060228358 Antibody molecules having specificity for human il-1 beta |
| 10/12/2006 | US20060228356 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease |
| 10/12/2006 | US20060228355 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
| 10/12/2006 | US20060228354 Modified ADAMTS4 molecules and method of use thereof |
| 10/12/2006 | US20060228353 PTH1R and PTH3R receptors, methods and uses thereof |
| 10/12/2006 | US20060228351 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor |
| 10/12/2006 | US20060228350 Framework-shuffling of antibodies |
| 10/12/2006 | US20060228346 Constitutively active phosphatidylinositol 3-kinase and uses thereof |
| 10/12/2006 | US20060228343 Cardiac glycoside resistant non-immunogenic selection marker |
| 10/12/2006 | US20060228335 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 10/12/2006 | US20060228332 Assembly and folding of Fc-interferon-beta fusion proteins |
| 10/12/2006 | US20060228331 IL-21 Derivatives and variants |
| 10/12/2006 | US20060228330 Dominant negative proteins and methods thereof |
| 10/12/2006 | US20060228329 Homogeneous preparations of IL-31 |
| 10/12/2006 | US20060228326 Active specific immunotherapy of cancer metastasis |
| 10/12/2006 | DE4237113B4 Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins Peptides and fusion proteins, expression vector and methods for producing a fusion protein |
| 10/12/2006 | CA2604488A1 Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines |
| 10/12/2006 | CA2603408A1 Process for production of polypeptide by regulation of assembly |